Attorneys React To High Court's Gene Patent Ruling

Law360, New York (June 13, 2013, 11:04 PM EDT) -- The U.S. Supreme Court ruled unanimously Thursday that human genes cannot be patented, striking down Myriad Genetics Inc.'s patents on isolated DNA associated with an increased risk of breast cancer. Here, attorneys tell Law360 why the unanimous ruling is significant.

Bruce Abramson, Rimon PC

"While it does not comport to my understanding of the facts, it nevertheless represents proper judicial reasoning. I was heartened to see that the court did not delve into the public policy debates about either the exclusive ownership of therapeutic treatments or...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.